Phase II Clinical Trial of NEPA (Netupitant/Palonosetron) for Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) in Patient Receiving the BEAM Conditioning Regimen

被引：0
|
作者：
Bubalo, Joseph [1 ]
Chen, Andy I. [2 ]
Leong, Kelli [3 ]
Gille, Bianca [4 ]
Nagle, Sarah [5 ]
Bensch, Kenneth [4 ]
Macey, Tara [4 ]
Ellison, Kelly [4 ]
Booth, Georgeann [4 ]
Misra, Shikha [4 ]
Maziarz, Richard T. [6 ]
机构：
[1] Oregon Hlth & Sci Univ Hosp, Pharm Serv, CR 9-4, Portland, OR USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Ctr Hematol Malignancies, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ Hosp, Pharm, Portland, OR USA
[4] Oregon Hlth & Sci Univ Hosp, Portland, OR USA
[5] Oregon Hlth & Sci Univ Hosp, Portland, PA USA
[6] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
414
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase III study of NEPA, a fixed combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).
    Zhang, Li
    Lu, Shun
    Feng, Ji Feng
    Dechaphunkul, Arunee
    Chessari, Salvatore
    Lanzarotti, Corinna
    Jordan, Karin
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Netupitant/palonosetron (NEPA) for prevention of delayed chemotherapy-induced nausea and vomiting (CINV) in multiple cycles of chemotherapy.
    Schwartzberg, Lee Steven
    Gralla, Richard J.
    Kashef, Kimia
    Rugo, Hope
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (29)
  • [3] A phase II trial of olanzapine and palonosetron for the prevention of chemotherapy induced nausea and vomiting (CINV).
    Navari, R. M.
    Einhorn, L. H.
    Loehrer, P. J.
    Passik, S. D.
    Vinson, J.
    McClean, J.
    Chowhan, N.
    Hanna, N.
    Calley, C.
    Yu, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 495S - 495S
  • [4] NEPA <sc>(</sc>Netupitant/Palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Patients Receiving Highly or Moderately Emetogenic Chemotherapy Who Experienced Breakthrough CINV in Cycle 1 of Chemotherapy: A Phase II Clinical Trial
    Navari, Rudolph M.
    Bonizzoni, Erminio
    CANCER MEDICINE, 2025, 14 (07):
  • [5] NETUPITANT AND PALONOSETRON (NEPA), IS A COST-EFFECTIVE INTERVENTION FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) IN SINGAPORE
    Lim, S. W.
    Loh, K. W. J.
    Boisseau, S.
    Ho, W. T.
    Qasuri, M.
    D'agostino, P.
    Turini, M. M.
    Bourhis, F.
    Eriksson, J.
    Hadjiat, Y.
    VALUE IN HEALTH, 2019, 22 : S475 - S476
  • [6] NEPA (Netupitant plus palonosetron) for the prevention of nausea and vomiting in patients receiving high emetogenic conditioning regimen for Stem Cell Transplantation
    Corrochano, Mariana
    Moreno Martinez, M. Estela
    Garcia Cadenas, Irene
    Barata, Anna
    Feliu, Anna
    Esquirol, Albert
    Gomis, Mar
    Martino, Rodrigo
    Sierra, Jordi
    BONE MARROW TRANSPLANTATION, 2018, 53 : 348 - 349
  • [7] Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Baron-Hay, Sally
    Aapro, Matti
    Bernareggi, Alberto
    Schwartzberg, Lee
    SUPPORTIVE CARE IN CANCER, 2019, 27 (04) : 1309 - 1317
  • [8] Timing flexibility of oral NEPA, netupitant-palonosetron combination, administration for the prevention of chemotherapy-induced nausea and vomiting (CINV)
    Sally Baron-Hay
    Matti Aapro
    Alberto Bernareggi
    Lee Schwartzberg
    Supportive Care in Cancer, 2019, 27 : 1309 - 1317
  • [9] A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation
    Bubalo, Joseph S.
    Radke, Jennifer L.
    Bensch, Kenneth G.
    Chen, Andy, I
    Misra, Shikha
    Maziarz, Richard T.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (02) : 304 - 312
  • [10] Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)
    Lorusso, Vito
    Russo, Anna
    Giotta, Francesco
    Codega, Paolo
    CORE EVIDENCE, 2020, 15 : 21 - 29
12345